Drug Chatter -- Tracking biopharma stock chatter

DrugPatentWatch - Biopharmaceutical Business Intelligence

Profile for Geron Corporation (GERN)

« Back to company index

GERN Chatter Timeline

Stock Ticker for GERN

Most Active Tweeters for GERN

UserTweets
@gcassidy718 6
@newsfilterio 3
@VisualStockRSRC 3
@Brandon555577 3
@BlueBioNow 2

Recent Tweets for GERN

gcassidy718 @gcassidy718
$GERN what a Company -4.03 % change recently https://t.co/REKjzFhD5H
October 20th 2019, 10:10pm
gcassidy718 @gcassidy718
$GERN Hoping to exit this position at some point . . . -4.03 % change recently https://t.co/REKjzFhD5H
October 19th 2019, 7:10pm
TickerSentiment @TickerSentiment
Sentiment for $GERN out of 4 total scores; 75 % is positive and 25 % is negative. #sentiment https://t.co/N3GL3kzq31
October 18th 2019, 7:10pm
SwingTradeBot @SwingTradeBot
200 DMA Support today: $GERN $HIIQ ... https://t.co/LjP7KUcNnp
October 18th 2019, 10:10am
newsfilterio @newsfilterio
Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) $GERN https://t.co/vPgze4IWg8
October 17th 2019, 4:10pm
Brandon555577 @Brandon555577
$GERN - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/CZvGlDJbDL
October 17th 2019, 4:10pm
VisualStockRSRC @VisualStockRSRC
$GERN - Geron Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://t.co/15DijmxMW9
October 17th 2019, 4:10pm
FlashAlert_me @FlashAlert_me
$GERN: Press Release published article on October 17, 16:10:00: Geron Reports Inducement Grants Under Nasdaq Listin… https://t.co/qFqHZ2oeng
October 17th 2019, 4:10pm
BlueBioNow @BlueBioNow
$GERN price movement 2.40 % https://t.co/MFBtbC8TfM
October 16th 2019, 3:10am
1035l @1035l
@BlackBoxGuru After getting dropped by JNJ I thought $gern was done ?
October 15th 2019, 8:10am
Stock_News_Now @Stock_News_Now
$GERN: New SEC Filing for GERN: Form 8-K (No. 0001206774-19-003542): https://t.co/x17EyXunyz
October 15th 2019, 7:10am
fintel_io @fintel_io
$GERN / Geron files form 8-K - Entry into a Material Definitive Agreement, Financial Statements and Exhibits, Creat… https://t.co/pJRF1rmtC5
October 15th 2019, 7:10am
Brandon555577 @Brandon555577
$GERN - Current Report Filing (8-k) https://t.co/59PtHWB5mL
October 15th 2019, 7:10am
VisualStockRSRC @VisualStockRSRC
$GERN - Current Report Filing (8-k) https://t.co/RnhQGUHnOD
October 15th 2019, 7:10am
confcalltran @confcalltran
Entry into a Material https://t.co/euMP17AGBe $GERN
October 15th 2019, 7:10am
FlashAlert_me @FlashAlert_me
$GERN filed form 8-K on October 15, 06:55:10: Item1.01: Entry into a Material Definitive Agreement https://t.co/UPSrFA4fwa
October 15th 2019, 6:10am
BlackBoxGuru @BlackBoxGuru
$GERN everyone and their mother knew Geron was taking this into phase 3. What was the big surprise?
October 14th 2019, 5:10pm
gcassidy718 @gcassidy718
$GERN price movement 6.25 % https://t.co/REKjzFhD5H
October 13th 2019, 1:10pm
TickerReport @TickerReport
Geron $GERN Trading 6.3% Higher https://t.co/vHDFZpe5YK
October 13th 2019, 10:10am
dailypoliticaln @dailypoliticaln
Geron $GERN Stock Price Up 6.3% https://t.co/gRt1gkosn1
October 13th 2019, 10:10am
ZolmaxNews @ZolmaxNews
Geron $GERN Trading 6.3% Higher https://t.co/yKl0ekSA6S
October 13th 2019, 10:10am
jerchess @jerchess
$GERN Dr. J is growing more bullish https://t.co/bMphNFNlSq
October 12th 2019, 6:10pm
gcassidy718 @gcassidy718
$GERN auction is now open. 6.25 % change recently https://t.co/REKjzFhD5H
October 12th 2019, 1:10pm
bbnsnews @bbnsnews
Geron Co. $GERN Given Consensus Recommendation of “Buy” by Analysts https://t.co/N9wIwlVhrz
October 12th 2019, 12:10pm
BlueBioNow @BlueBioNow
$GERN significant price movement on this stock 2.43 % change recently https://t.co/MFBtbC8TfM
October 12th 2019, 8:10am
macondailynews @macondailynews
Geron $GERN Stock Price Up 6.3% https://t.co/MnJDdlxov5
October 11th 2019, 9:10pm
MaisaCorp @MaisaCorp
$GERN has dosed the first patient in a phase III trial of its imetelstat drug candidate as a potential alternative… https://t.co/AWSEosfXHJ
October 11th 2019, 4:10pm
1000Shares @1000Shares
RT @ez_alertz: $GERN Geron Starts Enrollment in Phase III MDS Study on Imetelstat https://t.co/A7ZXjzhekQ
October 11th 2019, 12:10pm
Traderideas1 @Traderideas1
Now this sucker $GERN decided to move when I got out yesterday.
October 11th 2019, 12:10pm
COCKRELLGROUP @COCKRELLGROUP
$GERN Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes https://t.co/UMNU6cwtmn
October 11th 2019, 10:10am
COCKRELLGROUP @COCKRELLGROUP
$GERN announced start of enrollment in phase III MDS study, evaluating its sole pipeline candidate, imetelstat, for… https://t.co/u9qZUyCHNo
October 11th 2019, 10:10am
ez_alertz @ez_alertz
$GERN Geron Starts Enrollment in Phase III MDS Study on Imetelstat https://t.co/A7ZXjzhekQ
October 11th 2019, 10:10am
1stOncology @1stOncology
Geron Announces First Patient Dosed in #IMerge Phase 3 Clinical Trial in Lower Risk #MyelodysplasticSyndromes $GERN https://t.co/vxDcgPaD6k
October 11th 2019, 10:10am
OpenOutcrier @OpenOutcrier
$GERN (+1.4% pre) Geron launches late-stage IMerge trial in lower risk MDS - SA https://t.co/IEBlYInRHv
October 11th 2019, 8:10am
WallStCards @WallStCards
$GERN Geron launches late-stage IMerge trial in lower risk MDS
October 11th 2019, 8:10am
newsfilterio @newsfilterio
Geron launches late-stage IMerge trial in lower risk MDS $GERN https://t.co/StG0UXA8kM
October 11th 2019, 6:10am
MarketCurrents @MarketCurrents
$GERN - Geron launches late-stage IMerge trial in lower risk MDS https://t.co/FrS133lVxq
October 11th 2019, 6:10am
newswithvalue @newswithvalue
$GERN: Geron Announces First Patient Dosed in IMerge Phase 3 Clinical …: https://t.co/RJshTubok5
October 10th 2019, 6:10pm
TopStockAlerts1 @TopStockAlerts1
$GERN moving on news
October 10th 2019, 5:10pm
newsfilterio @newsfilterio
Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes $GERN https://t.co/2VA3yBMVyR
October 10th 2019, 5:10pm
StockAuthority @StockAuthority
$GERN Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic Syndromes
October 10th 2019, 5:10pm
Brandon555577 @Brandon555577
$GERN - Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic https://t.co/f86DG6jO5N
October 10th 2019, 5:10pm
VisualStockRSRC @VisualStockRSRC
$GERN - Geron Announces First Patient Dosed in IMerge Phase 3 Clinical Trial in Lower Risk Myelodysplastic https://t.co/cy2jzXTL3J
October 10th 2019, 5:10pm
gcassidy718 @gcassidy718
$GERN Would say I'm surprised, but I'm not. Will check ER. Might dabble again. Maybe. 2.48 % change recently https://t.co/REKjzFhD5H
October 10th 2019, 2:10pm
gcassidy718 @gcassidy718
$GERN Looking for any entry here......... ;) 2.13 % change recently https://t.co/REKjzFhD5H
October 9th 2019, 3:10pm
TekATL3 @TekATL3
$GERN watch this continue developing. Measured move to 2.25. Close above 1.80/.75 triggers a larger pattern https://t.co/EsgoiSmkXZ
October 9th 2019, 1:10am
IRAMarketReport @IRAMarketReport
Analysts Set Geron Co. $GERN PT at $3.90 https://t.co/NPSX9k57fm #markets
October 8th 2019, 11:10pm
chaffeybreeze @chaffeybreeze
Analysts Set Geron Co. $GERN PT at $3.90 https://t.co/P08nmtPBFf #stocks
October 8th 2019, 11:10pm
COCKRELLGROUP @COCKRELLGROUP
Geron $GERN eInvestor Presentation - Slideshow https://t.co/nfgWypYwYn
October 7th 2019, 10:10am
OlympiaReport @OlympiaReport
Geron Co. $GERN Expected to Announce Quarterly Sales of $140,000.00 https://t.co/bAvOSN0p3f
October 5th 2019, 2:10am

DrugPatentWatch - Make Better Decisions
Contact © thinkBiotech LLC 2004 - 2019. All rights reserved.